SC
LLY icon

Stance Capital’s Eli Lilly LLY Stock Holding History

Stance Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
1,530
+134
+10% +$137K 0.56% 67
2026
Q1 		$1.28M Buy
1,396
+19
+1% +$19.3K 0.62% 78
2025
Q4 		$1.48M Buy
+1,377
New +$1.32M 0.54% 45
2025
Q3 		– Sell
-1,586
Closed -$1.24M – 295
2025
Q2 		$1.24M Buy
1,586
+72
+5% +$55.9K 0.46% 134
2025
Q1 		$1.25M Buy
1,514
+1,190
+367% +$990K 0.92% 36
2024
Q4 		$250K Buy
+324
New +$268K 0.15% 43

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stance Capital's LLY Position: Q2 2026 in Review

Stance Capital increased its Eli Lilly (LLY) stake by 9.6% in Q2 2026, buying an estimated $137K and bringing the position to 1,530 shares worth $1.84M. The position accounts for 0.56% of the portfolio, ranked #67.

Stance Capital first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,627 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stance Capital held 1,530 shares of Eli Lilly worth $1.84M as of Q2 2026.
  • Stance Capital bought 134 Eli Lilly shares in Q2 2026, an estimated $137K.
  • Eli Lilly made up 0.56% of Stance Capital's portfolio in Q2 2026, its #67 holding.
  • Stance Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.